These changes were reduced in EphA4‐KO tumor‐bearing mice without IGF1 treatment compared to that of control WT tumor‐bearing mice and could be enhanced in EphA4‐KO tumor‐bearing mice with IGF1 treatment. This evidence concerns the gene IGF1 and neoplasm.